JT
FOLD

Jump Trading’s Amicus Therapeutics FOLD Stock Holding History

Jump Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-440
Closed -$597K – 779
2015
Q3 		$597K Buy
+440
New +$6.9K 0.01% 230

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Jump Trading's FOLD Position: Q4 2015 in Review

Jump Trading sold out of Amicus Therapeutics (FOLD) in Q4 2015, closing a stake of 12,863 shares — an estimated $175K sold.

Jump Trading first reported a position in FOLD in Q3 2015 and held it in 1 quarter. The position peaked at $175K in Q3 2015. 139 funds tracked by Wall St. Rank hold FOLD as of Q4 2015.

  • Jump Trading reported no remaining Amicus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Jump Trading sold 12,863 Amicus Therapeutics shares in Q4 2015, an estimated $175K.
  • Jump Trading first reported a position in Amicus Therapeutics in Q3 2015 and held it in 1 quarter.
  • Jump Trading's Amicus Therapeutics position peaked at $175K in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2015.

Based on Jump Trading's 13F filing for Q4 2015, filed 17 Feb 2016.